Wockhardt Ltd Quarterly Result

Wockhardt Ltd Quarterly Result

Image

Wockhardt Ltd

NSE: WOCKPHARMA

Net Profit - Last Quarter

₹ 164 Cr.

Last updated on: Jun 02, 2026

Wockhardt Ltd Quarterly Results Key Highlights

  • The revenue of Wockhardt Ltd for the Mar '26 is ₹ 1032 crore as compare to the Dec '25 revenue of ₹ 913 crore.
  • This represent the growth of 13.03% The ebitda of Wockhardt Ltd for the Mar '26 is ₹ 292 crore as compare to the Dec '25 ebitda of ₹ 192 crore.
  • This represent the growth of 52.08% The net profit of Wockhardt Ltd for the Mar '26 is ₹ 164 crore as compare to the Dec '25 net profit of ₹ 61 crore.
  • This represent the growth of 168.85%.

Wockhardt Ltd Quarterly Results Analysis

Market Price of Wockhardt Ltd

1M

1Y

3Y

5Y

Monitoring Wockhardt Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
02 Jun 20261968.65
01 Jun 20262151.85
29 May 20262030.7
27 May 20261771.65
26 May 20261703.95
25 May 20261639.35
22 May 20261575.35
21 May 20261601.1
20 May 20261611.3
19 May 20261622.2

Historical Revenue of Wockhardt Ltd

No data available

* All values are in crore

Historical EBITDA of Wockhardt Ltd

No data available

* All values are in crore

Historical Net Profit of Wockhardt Ltd

No data available

* All values are in crore

Wockhardt Ltd News Hub

Wockhardt reports consolidated net loss of Rs 14.00 crore in the June 2024 quarter

Net Loss of Wockhardt reported to Rs 14.00 crore in the quarter ended June 2024 as against net loss

Read more

09 Aug 24

Wockhardt to table results

Wockhardt will hold a meeting of the Board of Directors of the Company on 9 August 2024. Powered by

Read more

08 Aug 24

Wockhardt allots 8,610 equity shares under ESOS

Wockhardt has allotted 8,610 equity shares under ESOS in 26 August 2024. With this allotment, the pa

Read more

26 Aug 24

Wockhardt's investigational drug, Zaynich' demonstrates its ability to manage complex infections

In the past year, Wockhardt's investigational drug, Zaynich' (Zidebactam/Cefepime), has successfully

Read more

19 Sept 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

Oct 2024

PPT

Feb 2024

PPT

Mar 2022

PPT

About Wockhardt Ltd

  • Wockhardt Limited, incorporated in July, 1999 is a global pharmaceutical and biotechnology organization, providing affordable, high-quality medicines for a healthier world.
  • The Company is India's leading research-based global healthcare enterprise in fields of Pharmaceuticals, Biotechnology and a chain of advanced Super Speciality Hospitals.
  • It has 12 manufacturing locations and there are 3 locations where research and development activities are carried out. The Company has manufacturing and research facilities in India, USA & UK and a manufacturing facility in Ireland.
  • It has a significant presence in USA, Europe and India, with 83% of its global revenues coming from international businesses.
  • Wockhardt is the only company in the world where USFDA has given QIDP Status (Qualified lnfectious Diseases Programme) for 5 of Anti-bacterial discovery programmes - 2 of them are Gram Negative and 3 Gram Positive effective against untreatable 'Superbugs'.

FAQs for Quarterly Results of Wockhardt Ltd

What key financial metrics are included in Wockhardt Ltd's quarterly results?

Key financial metrics in Wockhardt Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Wockhardt Ltd announce its quarterly results?

Wockhardt Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Wockhardt Ltd's quarterly performance impact its stock price?

Wockhardt Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Wockhardt Ltd's quarterly results on dividends?

The impact of Wockhardt Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Wockhardt Ltd's quarterly results?

Yes, Wockhardt Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions